CMXC Announces Results of Preliminary Analysis of Metabolomic Assays

News   Feb 27, 2015

 
CMXC Announces Results of Preliminary Analysis of Metabolomic Assays
 
 
 

RELATED ARTICLES

Autism Risk Higher if Pregnant Mothers Have Infection Requiring Hospitalization

News

Studies have shown that mothers who experience an infection severe enough to require hospitalization during pregnancy are at higher risk of having a child with autism.

READ MORE

£2.2M Collaboration to Fuel Drug Developments for HIV

News

A collaboration between the University of Liverpool and the Johns Hopkins University School of Medicine (JHUSM) has been awarded a further £2.2M ($3M) to develop sophisticated new medicines for HIV.

READ MORE

Antibody Treatment Effective in Treatment-Resistant COPD Patients

News

The new study reports the results from two Phase III clinical trials evaluating the efficacy of mepolizumab, an antibody treatment that reduces the number of eosinophils in the blood, in moderate to severe treatment-resistant eosinophilic COPD.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE